Safety and efficacy of drug-eluting beads versus conventional bronchial arterial chemoembolization for lung cancer: a systematic review and meta-analysis - Top-Institutions - MDSpire

Comparative Analysis of Drug-Eluting Beads and Standard Bronchial Arterial Chemoembolization for Lung Cancer: A Systematic Review and Meta-Analysis

  • By

  • Zezhong Gong

  • Yali Liu

  • Yusheng Song

  • Xinghai Li

  • Yunfei Tian

  • Jing Li

  • Chaoyi Qi

  • July 21, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Interventional Radiology

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Oncology
    • Interventional Radiology

  • #3

    Affiliated Hospital of North Sichuan Medical College
    Affiliated Hospital of North Sichuan Medical College

    Nanchong, Sichuan

    Key Differentiators

    • Oncology

  • #4

    Keck School of Medicine at the University of Southern California
    Keck School of Medicine at the University of Southern California

    Los Angeles, California

    Key Differentiators

    • Oncology

  • #5

    Shanghai Putuo Central Hospital
    Shanghai Putuo Central Hospital

    Shanghai, Shanghai

    Key Differentiators

    • Oncology

Original Source(s)

Safety and efficacy of drug-eluting beads versus conventional bronchial arterial chemoembolization for lung cancer: a systematic review and meta-analysis

  • by Zezhong Gong, Yali Liu, Yusheng Song, Xinghai Li, Yunfei Tian, Jing Li, Chaoyi Qi

  • July 21, 2026

Related Content

Immune checkpoint inhibitor-induced diabetes mellitus in metastatic NSCLC: a case report with extended follow-up and management considerations

Translating physical stress into biological signals: precision electro-oncology based on conformational changes of electro-sensitive receptors and parameterized immune remodeling

Beyond the platform: why surgical quality and surgeon proficiency outweigh the RATS vs. VATS debate in early-stage lung cancer